litlas
Log inCreate account

Hys Ngan

Active 1978–2025

129
Papers
19,782
Citations
80
h-index
127
i10-index

Citations

Citations per year for Hys Ngan1979: 2 citations1980: 1 citations1984: 2 citations1991: 2 citations1992: 3 citations1993: 2 citations1994: 3 citations1995: 3 citations1996: 3 citations1997: 8 citations1998: 5 citations1999: 4 citations2000: 13 citations2001: 20 citations2002: 36 citations2003: 57 citations2004: 68 citations2005: 66 citations2006: 89 citations2007: 84 citations2008: 102 citations2009: 146 citations2010: 132 citations2011: 157 citations2012: 191 citations2013: 142 citations2014: 142 citations2015: 133 citations2016: 107 citations2017: 111 citations2018: 99 citations2019: 484 citations2020: 578 citations2021: 536 citations2022: 419 citations2023: 309 citations2024: 567 citations2025: 264 citations2026: 6 citations1981–1983: no citations, so these years are not shown1985–1990: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorChina: 1,426 citing papers, 20.6% of this breakdownUnited States: 1,328 citing papers, 19.2% of this breakdownUnited Kingdom: 352 citing papers, 5.1% of this breakdownItaly: 342 citing papers, 4.9% of this breakdownJapan: 252 citing papers, 3.6% of this breakdownGermany: 221 citing papers, 3.2% of this breakdownIndia: 185 citing papers, 2.7% of this breakdownCanada: 182 citing papers, 2.6% of this breakdownSpain: 182 citing papers, 2.6% of this breakdownHong Kong: 180 citing papers, 2.6% of this breakdownSouth Korea: 179 citing papers, 2.6% of this breakdownFrance: 176 citing papers, 2.6% of this breakdown
0%20.6%Other 27.7%

Institutions

Fields

  • Medicine60.7%
  • Biochemistry, Genetics and Molecular Biology32.3%
  • Immunology and Microbiology2.9%
  • Neuroscience0.5%
  • Engineering0.5%
  • Computer Science0.4%
  • Other2.7%

Topics

  • Hepatocellular Carcinoma Treatment and Prognosis5.4%
  • Endometrial and Cervical Cancer Treatments5.2%
  • Ovarian cancer diagnosis and treatment4.6%
  • MicroRNA in disease regulation2.4%
  • Cervical Cancer and HPV Research2.4%
  • Cancer, Hypoxia, and Metabolism2.3%
  • Other77.7%

Coauthors

All papers

Open in search
  1. SCD1/FADS2 fatty acid desaturases equipoise lipid metabolic activity and redox-driven ferroptosis in ascites-derived ovarian cancer cells

    Authors: Xuan Yang, Huogang Wang, Mingo M. H. Yung, Fushun Chen, Wai-Sun Chan, Yau-Sang Chan, Stephen Kwok‐Wing Tsui, Hys Ngan, Karen K. L. Chan, David W. Chan - Theranostics 2022 cited by 251

  2. The Impact of the Tumor Microenvironment on Macrophage Polarization in Cancer Metastatic Progression

    Authors: Huogang Wang, Mingo M. H. Yung, Hys Ngan, Karen K. L. Chan, David W. Chan - International Journal of Molecular Sciences 2021 cited by 246

  3. Molecular Biomarkers for the Early Detection of Ovarian Cancer

    Authors: Ruiqian Zhang, Michelle K.Y. Siu, Hys Ngan, Karen K. L. Chan - International Journal of Molecular Sciences 2022 cited by 261

  4. Tumor-secreted exosomal miR-141 activates tumor-stroma interactions and controls premetastatic niche formation in ovarian cancer metastasis

    Authors: Yulan Mo, Leanne Lee Leung, Celia S. L. Mak, Xueyu Wang, Wai-Sun Chan, Lynn Hui, Hermit Wai‐Man Tang, Michelle K.Y. Siu, Rakesh Sharma, Dakang Xu, Stephen Kwok‐Wing Tsui, Hys Ngan, Mingo M. H. Yung, Karen K. L. Chan, David W. Chan - Molecular Cancer 2023 cited by 94

  5. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

    Authors: Chung‐Mau Lo, Hys Ngan, Wai‐Kuen Tso, Chi‐Leung Liu, Chi‐Ming Lam, Ronnie Tung‐Ping Poon, Sheung-Tat Fan, John Wong - Hepatology 2002 cited by 2,627

  6. MAP30 protein from Momordica charantia is therapeutic and has synergic activity with cisplatin against ovarian cancer in vivo by altering metabolism and inducing ferroptosis

    Authors: David W. Chan, Mingo M. H. Yung, Yau-Sang Chan, Xuan Yang, Huijuan Yang, Dakang Xu, Jinbiao Zhan, Karen K. L. Chan, Tzi‐Bun Ng, Hys Ngan - Pharmacological Research 2020 cited by 125

  7. Soluble E-cadherin promotes tumor angiogenesis and localizes to exosome surface

    Authors: Maggie K. S. Tang, Patrick Ying‐Kit Yue, Philip P.C. Ip, Rui Huang, Hung-Cheng Lai, Any Cheung, Ka Yu Tse, Hys Ngan, Alice S.T. Wong - Nature Communications 2018 cited by 233

  8. Hexokinase 2 Regulates Ovarian Cancer Cell Migration, Invasion and Stemness via FAK/ERK1/2/MMP9/NANOG/SOX9 Signaling Cascades

    Authors: Michelle K.Y. Siu, Yuxin Jiang, Jingjing Wang, Thomas Leung, Chae Young Han, Benjamin K. Tsang, Any Cheung, Hys Ngan, Karen K. L. Chan - Cancers 2019 cited by 138

  9. Effect of Total Laparoscopic Hysterectomy vs Total Abdominal Hysterectomy on Disease-Free Survival Among Women With Stage I Endometrial Cancer

    Authors: Monika Janda, Val Gebski, Lucy Davies, Peta Forder, Alison H. Brand, Russell Hogg, Thomas W. Jobling, Russell Land, Tom Manolitsas, Marcelo Nascimento, Deborah Neesham, James Nicklin, Martin K. Oehler, Geoff Otton, Lewis Perrin, Stuart Salfinger, Ian Hammond, Yee Leung, Peter Sykes, Hys Ngan, Andrea Garrett, Michael Laney, Tong Yow Ng, Kar‐Fai Tam, Karen K. L. Chan, C. David Wrede, Selvan Pather, Bryony Simcock, Rhonda Farrell, Gregory Robertson, Graeme Walker, Nigel R Armfield, Nick Graves, Anthony J. McCartney, Andreas Obermair - JAMA 2017 cited by 418

  10. Diagnosis and Management of Gestational Trophoblastic Disease: 2021 Update

    Authors: Hys Ngan, Michael J. Seckl, Ross S. Berkowitz, Yang Xiang, François Golfier, Paradan K. Sekharan, John R. Lurain, Leon F.A.G. Massuger - International Journal of Gynecology & Obstetrics 2021 cited by 287

  11. Estrogen receptor modulators genistein, daidzein and ERB-041 inhibit cell migration, invasion, proliferation and sphere formation via modulation of FAK and PI3K/AKT signaling in ovarian cancer

    Authors: Karen K. L. Chan, Michelle K.Y. Siu, Yuxin Jiang, Jingjing Wang, Thomas Leung, Hys Ngan - Cancer Cell International 2018 cited by 120

  12. Paradoxical Impact of Two Folate Receptors, FRα and RFC, in Ovarian Cancer: Effect on Cell Proliferation, Invasion and Clinical Outcome

    Authors: Michelle K.Y. Siu, Daniel S. Kong, Hoi Yan Chan, Esther S.Y. Wong, Philip P.C. Ip, LiLi Jiang, Hys Ngan, Xiao-Feng Le, Any Cheung - PLoS ONE 2012 cited by 103

  13. Management and Care of Women With Invasive Cervical Cancer: American Society of Clinical Oncology Resource-Stratified Clinical Practice Guideline

    Authors: Linus Chuang, Sarah Temin, Rolando Camacho, Alfonso Dueñas‐González, Sarah Feldman, Murat Gültekin, Vandana Gupta, Susan Horton, Graciela Jacob, Elizabeth Kidd, Kennedy Lishimpi, Carolyn Nakisige, Joo‐Hyun Nam, Hys Ngan, William Small, Gillian Thomas, Jonathan S. Berek - Journal of Global Oncology 2016 cited by 200

  14. A Combination of Glutaminase Inhibitor 968 and PD-L1 Blockade Boosts the Immune Response against Ovarian Cancer

    Authors: Jingjing Wang, Michelle Kwan-Yee Siu, Yuxin Jiang, Thomas Leung, David W. Chan, Huogang Wang, Hys Ngan, Karen K. L. Chan - Biomolecules 2021 cited by 39

  15. Carcinoma of the Corpus Uteri

    Authors: WT CREASMAN, Franco Odicino, Patrick Maisonneuve, MA QUINN, U. Beller, JL BENEDET, A P Heintz, Hys Ngan, Sërgio Pecorelli - International Journal of Gynecology & Obstetrics 2006 cited by 979

  16. Targeting of lipid metabolism with a metabolic inhibitor cocktail eradicates peritoneal metastases in ovarian cancer cells

    Authors: Rain R. Chen, Mingo M. H. Yung, Xuan Yang, Shijie Zhan, Leanne Lee Leung, Rachel R. Liang, Thomas H. Y. Leung, Huijuan Yang, Dakang Xu, Rakesh Sharma, Karen K. L. Chan, Siew‐Fei Ngu, Hys Ngan, David W. Chan - Communications Biology 2019 cited by 105

  17. PDK1 promotes ovarian cancer metastasis by modulating tumor-mesothelial adhesion, invasion, and angiogenesis via α5β1 integrin and JNK/IL-8 signaling

    Authors: Michelle K.Y. Siu, Yuxin Jiang, Jingjing Wang, Thomas Leung, Siew‐Fei Ngu, Any Cheung, Hys Ngan, Karen K. L. Chan - Oncogenesis 2020 cited by 75

  18. RETRACTED ARTICLE: miR-137 mediates the functional link between c-Myc and EZH2 that regulates cisplatin resistance in ovarian cancer

    Authors: Jing Sun, Xin Cai, Mingo M. H. Yung, Wei Zhou, Jing Li, Yi Zhang, Zhuqing Li, Stephanie S. Liu, Any Cheung, Hys Ngan, Yiliang Li, Zhijun Dai, Kai Yan, Alexandros Tzatsos, Weiqun Peng, David W. Chan, Wenge Zhu - Oncogene 2018 cited by 142

  19. Ascites-derived ALDH+CD44+ tumour cell subsets endow stemness, metastasis and metabolic switch via PDK4-mediated STAT3/AKT/NF-κB/IL-8 signalling in ovarian cancer

    Authors: Yuxin Jiang, Michelle Kwan-Yee Siu, Jingjing Wang, Xue-Tang Mo, Thomas Leung, David W. Chan, Any Cheung, Hys Ngan, Karen K. L. Chan - British Journal of Cancer 2020 cited by 52

  20. Genome-wide DNA methylome analysis identifies methylation signatures associated with survival and drug resistance of ovarian cancers

    Authors: David W. Chan, Wai-Yip Lam, Fushun Chen, Mingo M. H. Yung, Yau-Sang Chan, Wai-Sun Chan, Fangfang He, Stephanie S. Liu, Karen K. L. Chan, Benjamin Li, Hys Ngan - Clinical Epigenetics 2021 cited by 44

  21. Aberrant upregulation of PDK1 in ovarian cancer cells impairs CD8+ T cell function and survival through elevation of PD-L1

    Authors: Jingjing Wang, Michelle K.Y. Siu, Yuxin Jiang, Thomas Leung, David W. Chan, Ranran Cheng, Any Cheung, Hys Ngan, Karen K. L. Chan - OncoImmunology 2019 cited by 38

  22. Update on the diagnosis and management of gestational trophoblastic disease

    Authors: Hys Ngan, Michael J. Seckl, Ross S. Berkowitz, Yang Xiang, François Golfier, Paradan K. Sekharan, John R. Lurain, Leon F.A.G. Massuger - International Journal of Gynecology & Obstetrics 2018 cited by 447

  23. Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial

    Authors: Ignace Vergote, Giovanni Scambia, David M. O’Malley, Ben Van Calster, Sang‐Yoon Park, Josep M. del Campo, Werner Meier, Aristotelis Bamias, Nicoletta Colombo, Robert M. Wenham, Al Covens, Christian Marth, Mansoor Raza Mirza, Judith R. Kroep, Haijun Ma, Cheryl A. Pickett, Bradley J. Monk, Ignace Vergote, Giovanni Scambia, Sangyoon Park, Yong Sang Song, Yulia Makarova, Joshua Trinidad, Hys Ngan, Aristotelis Bamias, Gerasimos Aravantinos, Joo‐Hyun Nam, Vera Gorbunova, Л. И. Крикунова, Duk‐Soo Bae, Jóse Ángel Arranz Arija, Mansoor Raza Mirza, Claudio Zamagni, Christos N. Papandreou, Francesco Raspagliesi, Alla Lisyanskaya, Ana Oaknin Benzaquen, Germana Tognon, Eugenia Ortega, Antonio Casado Herraez, Joseph Buscema, Andrew Green, Robert A. Burger, Dina Sakaeva, Andres Redondo Sanchez, Sharad Ghamande, Laurel A. King, Edgar Petru, Ulla Peen, Satoshi Takeuchi, Kimio Ushijima, Antonio González-Martı́n, Scott Kamelle, Michael E. Carney, Christian Marth, Frédéric Forget, J. Bentley, Jalid Sehouli, Nicoletta Colombo, Paolo Zola, Hidenori Kato, Natalya Fadeeva, Evgeny Gotovkin, Vladimir Vladimirov, Margarita Romeo Marin, Eva Guerra Alía, Mark S. Shahin, Snehalkumar M Bhoola, Krishnansu S. Tewari, Daniel M. Anderson, Brigitte Honhon, J. Pelgrims, Amit M. Oza, Jesús García-Donás Jiménez, Vincent Hansen, David M. O’Malley, Ivor Benjamin, Vincent Renard, Heidi Van den Bulck, Werner Meier, Claudia Haenle, G. Koumakis, Harushige Yokota, В.М. Попов, William E. Bradley, Robert M. Wenham, Robert H. Reid, Donna McNamara, Richard D. Friedman, Joyce N. Barlin, Nicola M. Spirtos, Julia Chapman, P. Sevelda, Manon Huizing, C. Lamot, Frédéric Goffin, Lionel D. Hondt, Allan Covens, Silvana Spadafora, Beate Rautenberg and 237 more - The Lancet Oncology 2019 cited by 86

  24. Carcinoma of the Ovary

    Authors: APM Heintz, Franco Odicino, Patrick Maisonneuve, MA QUINN, JL BENEDET, WT CREASMAN, Hys Ngan, S. Pecorelli, U. Beller - International Journal of Gynecology & Obstetrics 2006 cited by 1,284